Hepatic and renal expression of Oatp1 in obstructive uropathy. First detection of Oatp1 in urine, a potential biomarker

• Published in: Clinical and experimental pharmacology & physiology Vol. 48; no. 7; pp. 987 - 995
• Main Authors: Campagno, Romina V., Nosetto, Evangelina C., Brandoni, Anabel, Torres, Adriana M.
• Format: Journal Article
• Language: English
• Published: Australia Wiley Subscription Services, Inc 01-07-2021
• Subjects: Animals; biomarker; Biomarkers; Biomarkers - metabolism; Biomarkers - urine; Histopathology; kidney; Kidney - metabolism; Kidney - pathology; Kidneys; Liver; Liver - metabolism; Liver - pathology; liver‐kidney crosstalk; Male; Membranes; Nephropathy; Oatp1; obstructive nephropathy; Organic Anion Transporters, Sodium-Independent; Organic anion transporting polypeptide; Parameters; Polypeptides; Rats; Rats, Wistar; Renal function; Rodents; Ureteral Obstruction - metabolism; Ureteral Obstruction - pathology; Ureteral Obstruction - urine; kidney; liver-kidney crosstalk; Oatp1; biomarker; liver; obstructive nephropathy
• ISSN: 0305-1870; 1440-1681; 1440-1681
• DOI: 10.1111/1440-1681.13499

Obstructive renal diseases affect renal function and kidney integrity. Nevertheless, little is known about its systemic or extra‐renal effects. The organic anion transporting polypeptide 1 (Oatp1) is a carrier expressed in liver and kidneys. In this study, the hepatic and renal expression of Oatp1 was evaluated in rats with obstructive nephropathy. Moreover, the urinary excretion of Oatp1 (Oatp1u) was evaluated as a potential biomarker for this pathology. Male Wistar rats with bilateral ureteral obstruction for 5 hours (BUO5), 24 hours (BUO24) or sham operated were used. After 24 hours of ureteral releasing, liver and kidney functional parameters, histopathology, Oatp1 tissular expression and Oatp1u were evaluated. For Oatp1u evaluation two groups were added; BUO1 and BUO2 (1 and 2 hours of ureteral obstruction, respectively). Both liver and kidney functional parameters and histopathological studies showed alterations in BUO5 and BUO24. In hepatic homogenates, Oatp1 significantly decreased in BUO groups and in total liver membranes no modifications were observed. In renal homogenates, Oatp1 significantly decreased in BUO groups, but in apical kidney membranes, its expression was increased. Oatp1u was only detected in BUO groups, even in those (BUO1, BUO2) in which no alterations in the traditional parameters of renal function were observed. Modulations in liver and renal expression of Oatp1 could be an organism strategy to attenuate the effects of the disease and an attempt to maintain the complex organ cross‐talk between liver and kidneys. Oatp1u could be a new, early and specific biomarker of obstructive nephropathy.
Different modulation in liver and renal Oatp1 expression in BUO could be an organism strategy to attenuate the disease effects and an attempt to maintain the complex organ cross‐talk between liver and kidneys. Oatp1 was only detected in urine from BUO groups and could be a specific biomarker of obstructive nephropathy.